Aurora Cannabis Inc. (ACB) Stock Forecast & Price Target

Aurora Cannabis Inc. (ACB) has an ST Score of 50.9 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Analysts rate ACB a Hold, with a price target of $5.92 (+49.1% vs the current price). Our ST Score grades it C+ (50.9/100). The ST Score is a data-driven signal, not a recommendation.

Valuation B, Profitability D-, Financial Strength A, Momentum B+, Growth C+, Forecast B, Sentiment C+.

Aurora Cannabis Inc. (ACB) earns a valuation grade of B, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Aurora Cannabis Inc. (ACB) earns a growth grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Aurora Cannabis Inc. (ACB) earns a profitability grade of D-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Aurora Cannabis Inc. (ACB) earns a financial strength grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for Aurora Cannabis Inc. (ACB) is $5.92 from 14 analysts, which is +49.1% versus the recent price of $3.97.

Aurora Cannabis Inc. (ACB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.